Both in Pharmaceuticals
Innovator U.S. Equity Ultra Buffer ETF - November vs MRBL Enhanced Equity ETF
Over the past year UNOV returned +10.4% and EDGE returned +20.6%; their daily moves had a correlation of 0.94.
UNOV +10.4% EDGE +20.6%Growth of $1, one year, split-adjusted
| Metric | UNOV | EDGE |
|---|---|---|
| Price | $41.36 | $51.97 |
| Market cap | $106.5M | $12.5M |
| Today | −0.24% | −0.54% |
| 1 month | +0.6% | −0.3% |
| 6 months | +12.4% | +22.6% |
| Year to date | +8.7% | +14.5% |
| 1 year | +10.7% | +21.7% |
| Revenue growth (YoY) | +3.0% | — |
| Gross margin | 69.0% | — |
| Net margin | 8.0% | — |
| P/E (TTM) | 27.4× | — |
| Price / sales | 3.0× | — |
| Net cash | $2.8M | $1.2M |
| Dividend yield | — | — |
| Volatility (60d) | 5.1% | 10.7% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).